Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

被引:63
作者
Jaffar, S
Wilkins, A
Ngom, PT
Sabally, S
Corrah, T
Bangali, JE
Rolfe, M
Whittle, HC
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Trop & Infect Dis, Infect Dis Epidemiol Unit, London WC1E 7HT, England
[2] Royal Victoria Hosp, Banjul, Gambia
[3] MRC Labs, Fajara, Senegal
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1997年 / 16卷 / 05期
关键词
HIV-1; HIV-2; CD4; decline; pathogenesis; The Gambia;
D O I
10.1097/00042560-199712150-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increasing evidence suggests that the pathogenesis of HIV-1 is different from that of HIV-2. Thus, we have measured, longitudinally at various times over a median follow-up of 2.1 years, the percentage CD4(+) cells of 94 patients infected with HIV-1 and 164 patients infected with HIV-2. The pattern of decline of CD4% over time was linear for patients with either infection. Multilevel statistical modeling techniques showed that after stratifying for HIV status, the rate of decline of CD4% was faster among patients who died than among those who survived (difference in rate of decline = 2.34% CD4(+) cells/year; p = 0.0002). After stratifying for survival status, the rate of decline was faster and less variable among patients infected with HIV-1 than among patients infected with HIV-2 (difference in rate of decline = 1.12% CD4(+) cells/year; p = 0.05). The proportion of patients who showed no fall in CD4(+) cells was higher in HIV-2 than in HIV-1 infection (p = 0.026). These data suggest fundamental differences between the two infections, with HIV-1 being more pathogenic resulting in a faster and more homogeneous rate of decline than HIV-2. In HIV-2 infection, disease in many patients progresses slowly, but in some the advance is just as fast as that in HIV-1 infection. The reasons for this marked heterogeneity need elucidation to understand the disease and to target therapeutic interventions against HIV-2 in those most at risk.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 19 条
  • [1] EPIDEMIOLOGY AND TRANSMISSION OF HIV-2 - WHY THERE IS NO HIV-2 PANDEMIC
    DECOCK, KM
    ADJORLOLO, G
    EKPINI, E
    SIBAILLY, T
    KOUADIO, J
    MARAN, M
    BRATTEGAARD, K
    VETTER, KM
    DOORLY, R
    GAYLE, HD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (17): : 2083 - 2086
  • [2] DONNELLY C, 1993, B MATH BIOL, V55, P731, DOI 10.1007/BF02460671
  • [3] Goldstein H., 2010, Multilevel statistical models, V4th
  • [4] SLOWER HETEROSEXUAL SPREAD OF HIV-2 THAN HIV-1
    KANKI, PJ
    TRAVERS, KU
    MBOUP, S
    HSIEH, CC
    MARLINK, RG
    GUEYENDIAYE, A
    SIBY, T
    THIOR, I
    HERNANDEZAVILA, M
    SANKALE, JL
    NDOYE, I
    ESSEX, ME
    [J]. LANCET, 1994, 343 (8903) : 943 - 946
  • [5] IMMUNOLOGICAL COMPARISON OF HIV-1REACTIVE, HIV-2REACTIVE AND DUALLY-REACTIVE WOMEN DELIVERING IN ABIDJAN, COTE-DIVOIRE
    KESTENS, L
    BRATTEGAARD, K
    ADJORLOLO, G
    EKPINI, E
    SIBAILLY, T
    DIALLO, K
    GIGASE, PL
    GAYLE, H
    DECOCK, KM
    [J]. AIDS, 1992, 6 (08) : 803 - 807
  • [6] LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63
  • [7] LEGUENNO BM, 1991, J ACQ IMMUN DEF SYND, V4, P421
  • [8] Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau
    Lisse, IM
    Poulsen, AG
    Aaby, P
    Knudsen, K
    Dias, F
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 13 (04) : 355 - 362
  • [9] REDUCED RATE OF DISEASE DEVELOPMENT AFTER HIV-2 INFECTION AS COMPARED TO HIV-1
    MARLINK, R
    KANKI, P
    THIOR, I
    TRAVERS, K
    EISEN, G
    SIBY, T
    TRAORE, I
    HSIEH, CC
    DIA, MC
    GUEYE, E
    HELLINGER, J
    GUEYENDIAYE, A
    SANKALE, JL
    NDOYE, I
    MBOUP, S
    ESSEX, M
    [J]. SCIENCE, 1994, 265 (5178) : 1587 - 1590
  • [10] EPIDEMIOLOGIC CHARACTERISTICS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION IN AFRICA
    MIYAZAKI, M
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1995, 6 (02) : 75 - 80